TY - JOUR
T1 - SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan
AU - Mohamed, H.S.
AU - Ibrahim, M.E.
AU - Miller, E.N.
AU - White, J.K.
AU - Cordell, H.J.
AU - Howson, J.M.
AU - Peacock, C.S.
AU - Khalil, E.A.
AU - El Hassan, A.M.
AU - Blackwell, Jenefer
PY - 2004
Y1 - 2004
N2 - Genetic susceptibility to visceral leishmaniasis (VL) is indicated by differences in incidence and clinical phenotypes between ethnic groups in Sudan. In mice, innate susceptibility to Leishmania donovani, the etiological agent of VL, is controlled by Slc11a1 (formerly Nramp1). We therefore examined polymorphisms at SLC11A1 in 59 multicase families of VL from the high-incidence Masalit tribe in Sudan. Multipoint nonparametric analysis in ALLEGRO shows a significant linkage across SLC11A1 (Z(lr) scores 2.38-2.55; 0.008 less than or equal to P less than or equal to 0.012; information content 0.88). The extended transmission disequilibrium test shows biased transmission of alleles at 5' polymorphisms in the promoter (P = 0.0145), exon 3 (P = 0.0037) and intron 4 (P = 0.0049), and haplotypes formed by them (P = 0.0089), but not for 30 polymorphisms at exon 15 or the 3'UTR. Stepwise logistic regression analysis using a case/pseudo-control data set derived from the 59 families was consistent with main effects contributed by the intron 4 469+14G/C polymorphism. Although the two alleles for 469+14G/C lie on haplotypes carrying different alleles for the functional promoter GT(n) polymorphism, the latter did not itself contribute separate main effects. Sequence analysis of 36 individuals failed to identify new putative functional polymorphisms in the coding region, intron 1, intron/exon boundaries, intron 4/exon 4a, or in the 3'UTR. One novel promoter polymorphism (-86G/A) was located within a putative nuclear factor kappa B binding site that could be functional. Further work will determine whether additional polymorphisms occur upstream in the promoter, which could be in linkage disequilibrium with the intron 4 polymorphism. These studies contribute to knowledge of the role of SLC11A1 in infectious disease.
AB - Genetic susceptibility to visceral leishmaniasis (VL) is indicated by differences in incidence and clinical phenotypes between ethnic groups in Sudan. In mice, innate susceptibility to Leishmania donovani, the etiological agent of VL, is controlled by Slc11a1 (formerly Nramp1). We therefore examined polymorphisms at SLC11A1 in 59 multicase families of VL from the high-incidence Masalit tribe in Sudan. Multipoint nonparametric analysis in ALLEGRO shows a significant linkage across SLC11A1 (Z(lr) scores 2.38-2.55; 0.008 less than or equal to P less than or equal to 0.012; information content 0.88). The extended transmission disequilibrium test shows biased transmission of alleles at 5' polymorphisms in the promoter (P = 0.0145), exon 3 (P = 0.0037) and intron 4 (P = 0.0049), and haplotypes formed by them (P = 0.0089), but not for 30 polymorphisms at exon 15 or the 3'UTR. Stepwise logistic regression analysis using a case/pseudo-control data set derived from the 59 families was consistent with main effects contributed by the intron 4 469+14G/C polymorphism. Although the two alleles for 469+14G/C lie on haplotypes carrying different alleles for the functional promoter GT(n) polymorphism, the latter did not itself contribute separate main effects. Sequence analysis of 36 individuals failed to identify new putative functional polymorphisms in the coding region, intron 1, intron/exon boundaries, intron 4/exon 4a, or in the 3'UTR. One novel promoter polymorphism (-86G/A) was located within a putative nuclear factor kappa B binding site that could be functional. Further work will determine whether additional polymorphisms occur upstream in the promoter, which could be in linkage disequilibrium with the intron 4 polymorphism. These studies contribute to knowledge of the role of SLC11A1 in infectious disease.
UR - https://www.scopus.com/pages/publications/10744230828
U2 - 10.1038/sj.ejhg.5201089
DO - 10.1038/sj.ejhg.5201089
M3 - Article
SN - 1018-4813
VL - 12
SP - 66
EP - 74
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 1
ER -